The contralateral breast at reconstructive surgery after breast cancer operation — A histopathological study Anita RingbergBjörn PalmerFolke Linell Report Pages: 151 - 161
Luteal phase defect and breast cancer genesis Pierre Mauvais-JarvisRégine Sitruk-WareFrédérique Kuttenn Review Pages: 139 - 150
Metabolites of tamoxifen in animals and man: Identification, pharmacology, and significance V. Craig JordanC. Chem. Review Pages: 123 - 138
Quality control for estrogen receptor quantification by dextran-coated charcoal assay: A single laboratory's experience Shanthi RaamRebecca GelmanJoseph L. Cohen Reports Pages: 111 - 117
The axillary nodes and tumor size in breast cancer F. HartveitM. TangenJ. F. Halvorsen Reports Pages: 105 - 109
Bilateral ovariectomy in premenopausal patients with advanced breast cancer, after the evaluation of estrogen receptors and urinary androgen excretion Saro OrianaGiorgio SecretoFerdinando Preda Reports Pages: 101 - 104
A phase II trial of tamoxifen, premarin, methotrexate and 5-fluorouracil in metastatic breast cancer Joseph C. AllegraThomas M. WoodcockJames L. Wittliff Reports Pages: 93 - 99
Autologous bone marrow transplantation in metastatic breast cancer Patricia S. Stewart Fourth Annual San Antonio Breast Cancer Symposium Pages: 85 - 92
Adjuvant therapy of breast cancer 1971–1981 Paul P. Carbone Fourth Annual San Antonio Breast Cancer Symposium Pages: 75 - 84
Differentiation of the mammary gland and susceptibility to carcinogenesis Jose RussoLee K. TayIrma H. Russo Review Pages: 5 - 73
Growth regulation of two rat adenocarcinoma cell lines by dexamethasone and progesterone E. JolyF. VignonH. Rochefort Reports Pages: 381 - 389
Nil-8 conditioned medium stimulates growth of human mammary epithelial cells Ian S. FentimanJacky HurstJoyce Taylor-Papadimitriou Reports Pages: 375 - 379
Total prolactin binding sites in human breast cancer biopsies J. P. PeyratD. DewaillyJ. Lefebvre Reports Pages: 369 - 373
Lack of efficacy of xeromammography in preoperatively detecting lobular carcinoma in situ of the breast Don M. MorrisAlonzo P. WalkerDonald C. Coker Reports Pages: 365 - 368
Effect of chemotherapy on survival in metastatic breast cancer Alexander H. G. PatersonOlga SzafranJohn Hanson Reports Pages: 357 - 363
Adjuvant CMF effect on site of first recurrence, and appropriate follow-up intervals, in operable breast cancer with positive axillary nodes P. ValagussaJ. D. Tesoro TessG. Bonadonna Reports Pages: 349 - 356
Surgery in the primary treatment of breast cancer Norman WolmarkBernard Fisher 4th Annual San Antonio Breast Cancer Symposium Pages: 339 - 348
Cytochemistry of sex steroid receptors: A critique K. S. McCarty JrD. S. ReintgenK. S. McCarty Sr. Viewpoints Pages: 315 - 325
Immunohistologic and histochemical methods for detection of steroid binding in breast cancer: A reappraisal Louis P. PertschukEllis H. TobinNorman D. Bloom Viewpoints Pages: 297 - 314
Corpus luteum dysfunction and the epidemiology of breast cancer: A reconsideration Barry M. ShermanRobert B. WallaceStanley G. Korenman Review Pages: 287 - 296
Glycosylated haemoglobin levels in breast cancer patients receiving cytotoxic chemotherapy B. CantwellI. F. ShirleyJ. J. Fennelly Correspondence Pages: 281 - 282
Repeat screening by single oblique view mammography Bengt LundgrenSören Jakobsson Reports Pages: 273 - 280
Factors affecting dehydroepiandrosterone sulphate levels in human breast secretions W. R. MillerV. HumeniukA. P. M. Forrest Reports Pages: 267 - 272
Tumour steroid hormone synthesis and estrogen receptor status in breast cancer patients R. C. MasonD. A. BurnsA. P. M. Forrest Reports Pages: 263 - 266
Relationship among estrogen receptors, proliferative activity and menopausal status in breast cancer Armando BertuzziMaria Grazia DaidoneRosella Silvestrini Reports Pages: 253 - 262
Oestrogen receptor concentration in primary breast cancer and axillary node metastases Richard Anthony HawkinsRobert BlackAndrew Patrick McEwan Forrest Reports Pages: 245 - 251
Prolactin binding by human mammary carcinoma: Relationship to estrogen receptor protein concentration and patient age Barbara Rae-VenterTakuma NemotoThomas L. Dao Reports Pages: 233 - 243
The prophylaxis of rat and mouse mammary gland tumorigenesis by suppression of prolactin secretion: A reappraisal Clifford W. WelschMargaret Goodrich-SmithLeslie Roth Reports Pages: 225 - 232
Estradiol stimulates synthesis of a major intracellular protein in a human breast cancer cell line (MCF-7) Dean P. EdwardsDavid J. AdamsWilliam L. McGuire Reports Pages: 209 - 223
Karyotype analysis of a human mammary sarcoma explant in vitro T. R. ChenG. Seman Reports Pages: 203 - 208
Suppression of estrogens with Aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: A review R. J. Santen Review Pages: 183 - 202
Potential and problems with growth of breast cancer in a human tumor cloning system Daniel D. Von HoffJohn Sandbachthe South Central Texas Human Tumor Cloning Group US-Japan Conference on Chemoendocrine Therapy Pages: 141 - 148
Hormone receptors and obesity in Japanese women with breast cancer Keijiro KunoAtsuo FukamiFujio Kasumi US-Japan Conference on Chemoendocrine Therapy Pages: 135 - 139
Adjuvant therapy for stage II, estrogen receptor negative breast cancer William A. Knight IIIGary M. ClarkWilliam L. McGuire US-Japan Conference on Chemoendocrine Therapy Pages: 131 - 134
Oral high-dose medroxyprogesterone acetate (MAP) in treatment of advanced breast cancer Masaru IzuoYuichi IinoKeiichi Endo US-Japan Conference on Chemoendocrine Therapy Pages: 125 - 130
Combined chemo-hormonal therapy in breast cancer: A hypothesis C. Kent Osborne US-Japan Conference on Chemoendocrine Therapy Pages: 121 - 123
A prospective evaluation of chemohormonal therapy remission maintenance in advanced breast cancer Douglass C. TormeyRebecca GelmanGeoffrey Falkson US-Japan Conference on Chemoendocrine Therapy Pages: 111 - 119
Chemoendocrine therapy in advanced breast cancer David T. KiangB. J. Kennedy US-Japan Conference on Chemoendocrine Therapy Pages: 105 - 109
Sequential endocrine therapy and chemotherapy in metastatic breast cancer: Effects on survival Andrea ManniOlof H. PearsonBahauddin M. Arafah US-Japan Conference on Chemoendocrine Therapy Pages: 97 - 103
Medical adrenalectomy in patients with advanced breast cancer resistant to anti-oestrogen treatment Robin M. L. MurrayPaula Pitt Report Pages: 91 - 95